Nature Reviews Molecular Cell Biology 13, 239–250 (2012)
On page 250 of this article, the competing financial interests statement incorrectly stated that the authors had no competing interests. The authors' statement is reproduced below, and the article has been corrected online. The editors apologize for this omission.
Competing financial interests statement Anders M. Näär has patents pending on miR-33a and miR-33b antisense targeting for the treatment of cardiometabolic disorders. These patents have been licensed by Santaris Pharma, Denmark. Veerle Rottiers declares no competing financial interests.
Additional information
The online version of the original article can be found at 10.1038/nrm3313
Rights and permissions
About this article
Cite this article
Rottiers, V., Näär, A. Erratum: MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol 13, 1 (2012). https://doi.org/10.1038/nrm3328
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrm3328
